Search results
Results from the WOW.Com Content Network
Renal biopsy (also kidney biopsy) is a medical procedure in which a small piece of kidney is removed from the body for examination, usually under a microscope. [1] Microscopic examination of the tissue can provide information needed to diagnose, monitor or treat problems of the kidney.
A kidney biopsy will provide a fully definitive diagnosis of nephritic syndrome and may also reveal the underlying cause of the nephritic syndrome depending on the underlying pathological process. On biopsy , a patient with nephritic syndrome would show inflammation of numerous glomeruli .
An estimate of the GFR is used clinically to determine the degree of kidney impairment and to track the progression of the disease. The GFR, however, does not reveal the source of the kidney disease. This is accomplished by urinalysis, measurement of urine protein excretion, kidney imaging, and, if necessary, kidney biopsy. [1]
These may include urine sediment analysis, renal ultrasound and/or kidney biopsy. Indications for kidney biopsy in the setting of AKI include the following: [17] Unexplained AKI, in a patient with two non-obstructed normal sized kidneys. AKI in the presence of the nephritic syndrome. Systemic disease associated with AKI. Kidney transplant ...
Rapidly progressive glomerulonephritis (RPGN) is a syndrome of the kidney that is characterized by a rapid loss of kidney function, [4] [5] (usually a 50% decline in the glomerular filtration rate (GFR) within 3 months) [5] with glomerular crescent formation seen in at least 50% [5] or 75% [4] of glomeruli seen on kidney biopsies.
Membranous glomerulonephritis (MGN) is a slowly progressive disease of the kidney affecting mostly people between ages of 30 and 50 years, usually white people (i.e., those of European, Middle Eastern, or North African ancestry.) [citation needed].
Micrograph of a kidney biopsy stained with a Jones stain. Jones' stain, also Jones stain, is a methenamine silver–periodic acid–Schiff stain used in pathology. [1] It is also referred to as methenamine PAS which is commonly abbreviated MPAS. It stains for basement membrane and is widely used in the investigation of medical kidney diseases.
Membranoproliferative glomerulonephritis (MPGN) is a type of glomerulonephritis caused by deposits in the kidney glomerular mesangium and basement membrane thickening, [2] activating the complement system and damaging the glomeruli. MPGN accounts for approximately 4% of primary renal causes of nephrotic syndrome in children and 7% in adults. [3]